Medical University of Vienna - Division of General Anaesthesia and Intensive Care Medicine
Vienna, 1090, Austria
NCT Number: NCT04612816
Prehospital emergency ultrasound (PEU) is being increasingly used in different preclinical emergency systems across the world. Ultrasound examinations in emergency situations, however, remain challenging even in the hospital setting despite the availability of standardized approaches such as Focused Assessment with Sonography for Trauma (FAST). Preclinical circumstances further complicate the adequate execution of an additional diagnostic tool such as PEU on the scene or inside a medical emergency vehicle. Furthermore, rapid translation of ultrasound findings into meaningful therapeutic consequences is considerably demanding in an environment of limited resources. If focused PEU is correctly used and patients' condition allows emergency doctors a careful ultrasound examination, it is possible to differentiate life-threatening diagnoses. PEU should be implemented in the management of emergency patients affected by trauma, cardiac arrest/shock or respiratory problems. To date it is unclear whether PEU results in improved outcome.
Some emergency cases present difficult challenges in the prehospital ultrasound examination. Portable devices designed for PEU suggest the possibility of increasing the use of ultrasound "in the field". However, to the investigator's knowledge, opportunities for real-time consultation with a second specialist including live transmission of the ultrasound picture are not being provided at any preclinical emergency facility.
Looking for future studies?
Notify Me18 year–116 year
All sexes
Observational
Vienna, 1090, Austria
Aim 1:
Feasibility of real time prehospital emergency ultrasound (PEU) transmission in a university affiliated preclinical emergency system.
Aim 2:
Identify obstacles for PEU transmission including a real time consultation of an ultrasound expert.
Hypothesis:
We expect that live streaming of emergency ultrasound images in order to allow a second opinion could improve diagnostics of life threatening conditions and help us to improve patients' safety by digital health. The use of PEU is feasible and safe.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Emergency patients affected by:
Exclusion criteria
Feasibility of real time PEU transmission in a university affiliated preclinical emergency system.
Time frame: 3 Months
Numerical scale (1-10; 1 = best, 10 = poor)
Time frame: 3 Months
Expert available on time? Communication? Duration of ultrasound examination? Duration of live stream? Delay by PEU transmission? Emergency duration with/without PEU transmission Technical problems?
Time frame: 3 Months
Communication?
Time frame: 3 Months
Duration of ultrasound examination?
Time frame: 3 Months
Duration of live stream?
Time frame: 3 Months
Delay by PEU transmission?
Time frame: 3 Months
Emergency duration with/without PEU transmission technical problems?
Medical University of Vienna
Other
Live Stream of Emergency Ultrasound to Improve Diagnostics in Prehospital Medical Care: a Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06837532
Local Anesthesia Infiltration, Postoperative Analgesia
Cairo, Egypt
View Trial DetailsNCT06728709
Gynecologic Cancer, Lung Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05857852
Chemically-Induced Disorders, Cocaine Abuse
Charlottesville, Virginia, United States
View Trial DetailsNCT07579533
Adenocarcinoma, Carcinoma
Changchun, Jilin, China
View Trial Details